Neurol. praxi. 2022;23(1):33-35 | DOI: 10.36290/neu.2021.069

Neuropsychiatric comorbidities in patients with DMD

MUDr. Lenka Juříková, MUDr. Pavlína Danhofer, Ph.D., MUDr. Zdenka Bálintová, Mgr. Jana Pejčochová, doc. MUDr. Hana Ošlejšková, Ph.D.
Klinika dětské neurologie LF MU a FN Brno

Duchenne/Becker muscular dystrophy, caused by mutations in dystrophin gene,is one of the most frequent muscular dystrophies. Symptoms of DMD include typical movement problems, cardiomyopathy and respiratory failure most often occur in the third decade. In many patients we can find not only movement problems but also neuropsychiatric disorders, esp. autism spectrum disorders, attention-deficit hyperactivity disorder and obsessive-compulsive disorder. Their incidence is higher than in other population. Probabaly it due to lack of dystrophin in neurons.

Keywords: Duchenne/Becker muscular dystrophy, autism spectrum disorders, attention-deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD).

Received: August 12, 2021; Revised: September 14, 2021; Accepted: September 15, 2021; Prepublished online: September 15, 2021; Published: March 14, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Juříková L, Danhofer P, Bálintová Z, Pejčochová J, Ošlejšková H. Neuropsychiatric comorbidities in patients with DMD. Neurol. praxi. 2022;23(1):33-35. doi: 10.36290/neu.2021.069.
Download citation

References

  1. Banihani R, Smile S, Yoon G, et al. Cognitive and Neurobehavioral Profile in Boys With Duchenne Muscular Dystrophy. J Child Neurol. 2015;30:1472-1482. Go to original source... Go to PubMed...
  2. Bies RD, Phelps SF, Cortez MD, et al. Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development. Nucl. Acids Res. 1992;20:1725-1731. Go to original source... Go to PubMed...
  3. Duan D, Goemans N, Takeda S, et al. Duchenne muscular dystrophy. Nat Rev Dis. Primers. 2021;7:13. Go to original source... Go to PubMed...
  4. Gondžová V. Vybrané neurovývojové poruchy z pohledu dětského psychologa. Ošlejšková H. a kol. Dětská neurologie. Olomouc, Solen 2015; 226-240. ISBN 978-80-7471-124-4.
  5. Hendriksen JGM, Vles JSH. Neuropsychiatric disorders in males with Duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder and obsessive-compulsive disorder. J Child Neurol OnlineFirst, 2008. Go to original source... Go to PubMed...
  6. Moizard MP, Billard C, Toutin A, et al. Are Dp71 and Dp140 brain dystrophin isoforms related related to cognitive impairmen in Duchenne muscular dystrophy? Am J Med Genet. 1998;80:32-41. Go to original source...
  7. Mrázová L. Duchennova svalová dystrofie - patogeneze, klinický obraz, diagnostika, aktuální možnosti terapie. Neurológia. 2016;11(1):13-15.
  8. Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet neurol. 2003;2(12):731-740. Go to original source... Go to PubMed...
  9. Ošlejšková H, Pejčochová J. Autizmy. Cesk Slov Neurol N. 2010;73(6):627-641.
  10. Parisi L, Filippo T, Glorioso P, et al. Autism spectrum disorders in children affected by Duchenne muscular dystrophy. Minerva Pediatr. 2018;70(3):233-239. Go to original source... Go to PubMed...
  11. Praško J, Prašková H, Razska M, et al. Obsedantně kompulzivní porucha a její léčba. Med. Praxi. 2008;5(1):33-38.
  12. Wu JY, Kuban KCK, Allred E, et al. Association of Duchenne muscular dystrophy with autism spectrum disorders. J Child Neurol. 2005;20:790. Go to original source... Go to PubMed...
  13. Yiu EM, Kornberg AJ. Duchenne muscular dystrophy. Neurol India. 2008;56(3):236-247. Go to original source... Go to PubMed...
  14. Young HK, Barton BA, Waisbren S, et al. Cognitive and Psychological Profile of Males With Becker Muscular Dystrophy. J Child Neurol. 2008;23:155. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.